advertisement

---

Broadway DC 10

Showing records 1 to 10 | Display all abstracts from Broadway DC

60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Osborne A
PLoS ONE 2015; 10: e0115591

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304

---

60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Aldarwesh A
PLoS ONE 2015; 10: e0115591

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Crabb DP; Bunce C
Lancet 2015; 385: 1295-1304

---

60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Rhodes JD
PLoS ONE 2015; 10: e0115591

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Lascaratos G
Lancet 2015; 385: 1295-1304

---

60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Broadway DC; Everitt C
PLoS ONE 2015; 10: e0115591

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Amalfitano F
Lancet 2015; 385: 1295-1304

---

60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Sanderson J
PLoS ONE 2015; 10: e0115591

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Anand N; Azuara-Blanco A; Bourne RR; Broadway DC; Cunliffe IA; Diamond JP; Fraser SG; Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald
Lancet 2015; 385: 1295-1304

---